Literature DB >> 3050691

Botulinum toxin A-induced protective ptosis in corneal disease.

C M Kirkness1, G G Adams, P N Dilly, J P Lee.   

Abstract

Botulinum toxin A produces a temporary, flaccid ptosis when injected into the levator palpebrae superioris muscle. The resulting protective ptosis was used to aid healing in 21 cases of indolent ulceration, and, prophylactically, in 4 cases of neuroparalytic keratitis. Of the indolent ulcers, 90% healed completely. In all but one case, the cornea was covered completely by the lid and complete ptosis was produced in 75% of cases in an average of 3.6 days, lasting for 16 days on average before recovery began. Recovery of levator function was complete in 8.5 weeks on average. Superior rectus underaction was seen in 68% of cases but this recovered completely in all cases in an average of 6 weeks. Impression cytology showed a trend toward normal conjunctival morphology as healing progressed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050691     DOI: 10.1016/s0161-6420(88)33163-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

1.  Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group.

Authors:  Valerie P J Saw; Darwin Minassian; John K G Dart; Andrew Ramsay; Hugo Henderson; Stefan Poniatowski; Ruth M Warwick; Suzanne Cabral
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

2.  [Botulinum toxin injection for production of ptosis].

Authors:  R-L Merté; I M Lanzl
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

Review 3.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

4.  Botulinum toxin: a new ally of an old adversary.

Authors:  R C Humphry
Journal:  BMJ       Date:  1989-01-21

5.  Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database.

Authors:  Salma Ahsanuddin; Savannah Roy; Wissam Nasser; Roman Povolotskiy; Boris Paskhover
Journal:  Aesthetic Plast Surg       Date:  2020-10-30       Impact factor: 2.326

6.  Therapeutic ptosis with botulinum toxin in epikeratoplasty.

Authors:  T Freegard; I Mackie; C Rostron
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

7.  Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.

Authors:  Thomas Fuchsluger; Emre Tuerkeli; Henrike Westekemper; Joachim Esser; Klaus-Peter Steuhl; Daniel Meller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535

8.  A modified transconjunctival technique for botulinum toxin chemodenervation of levator palpebrae superioris for corneal protection.

Authors:  Naing L Tint; Edward P I Saxby; Su-Ling Young; Philip Alexander
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 4.456

Review 9.  Eye and Periocular Skin Involvement in Herpes Zoster Infection.

Authors:  Chris D Kalogeropoulos; Ioannis D Bassukas; Marilita M Moschos; Khalid F Tabbara
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2015

Review 10.  Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management.

Authors:  Flavio Mantelli; Chiara Nardella; Eloisa Tiberi; Marta Sacchetti; Alice Bruscolini; Alessandro Lambiase
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.